The 2026 Colorectal Cancer Landscape Report

Stay ahead of the curve with our 2026 Colorectal Cancer (CRC) Report, a comprehensive, data-driven overview of the CRC drug and clinical trial landscape, including insights into the key CRC drug development targets, top clinical trial biomarkers, leading clinical assets, and top CRC drug developers.

The Colorectal Cancer Report

Colorectal Cancer (CRC) remains one of the most prevalent cancers globally and a major focus for R&D investment as competition intensifies across treatment settings.

This Report Offers Insight Into:

  • Key Targets: Discover the key targets being investigated in CRC drug development, categorized by therapeutic class, so you don’t miss where the next wave of innovation is emerging.
  • Biomarkers: Explore the most studied biomarkers by trial phase, to stay aligned with evolving patient selection strategies.
  • Leading Clinical Assets: Uncover the drugs leading CRC clinical trial activity, so you can benchmark against the assets gaining the most traction.
  • Drug Developers: Identify the top developers driving progress across the CRC pipeline, to understand who you’re really competing with.
Colorectal Cancer Report 2026

You May Also Be Interested In…

Learn More About Oncology

What is Beacon Oncology?
  • The Most Comprehensive Way to Search the Oncology Drug Development Landscape: Unique search ontologies based on Oncology drug and trial characteristics
  • Market Leading Approach to Oncology Preclinical & Clinical Data Curation: Manual curation of key Oncology research and development data points by Oncology research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Oncology company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Oncology Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search